# Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer

> **NCT00859729** · PHASE1,PHASE2 · COMPLETED · sponsor: **Uppsala University** · enrollment: 15 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** pVAXrcPSAv53l (DNA encoding rhesus PSA)
- **DEVICE:** DERMA VAX™ intradermal DNA delivery system

## Key facts

- **NCT ID:** NCT00859729
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-03-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859729, "Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00859729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*